Polyomavirus BK-specific immunity after kidney transplantation.

Area of Science:

• Immunology
• Nephrology
• Virology

Background:

• Polyomavirus BK (BKV)-associated nephropathy (PVAN) is a significant complication after kidney transplantation.
• The role of BKV-specific immunity in the development and progression of PVAN remains incompletely understood.
• Limited data exist on BKV-specific immune responses in kidney transplant recipients.

Purpose of the Study:

• To investigate the BKV-specific cellular immune response in kidney transplant recipients with and without BKV infection or PVAN.
• To assess the correlation between BKV-specific immunity and the presence or absence of active BKV infection and PVAN.
• To explore the potential for immune recovery following immunosuppression modulation in PVAN patients.

Main Methods:

• Retrospective analysis of BKV-specific cellular immunity in kidney transplant recipients.
• Measurement of interferon (IFN)-gamma-secreting cells in peripheral blood as a marker of BKV-specific immune response.
• Comparison of immune cell frequencies between healthy controls, patients with BKV infection, and patients with PVAN.

Main Results:

• Patients with active BKV infection and good renal function showed significantly lower BKV-specific lymphocyte frequencies than healthy controls.
• Patients with PVAN exhibited undetectable levels of BKV-specific immune cells.
• Reduction in immunosuppression in two PVAN patients led to the emergence of detectable BKV-specific immunity, with IFN-gamma production comparable to healthy controls.

Conclusions:

• A lack of protective BKV-specific immunity appears to predispose kidney transplant recipients to active BKV infection and PVAN.
• Monitoring BKV-specific cellular immunity may aid in identifying patients at risk for PVAN.
• Immunosuppression management, including reduction, can potentially restore BKV-specific immune responses and impact PVAN progression.